List of Tables
Table 1. Global Meningioma Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Meningioma Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Meningioma Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Meningioma Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Meningioma Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Meningioma Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Meningioma Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Meningioma Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Meningioma Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningioma Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningioma Drug, Product Type & Application
Table 12. Global Key Manufacturers of Meningioma Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningioma Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningioma Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningioma Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Meningioma Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Meningioma Drug Sales Market Share by Region (2020-2025)
Table 19. Global Meningioma Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Meningioma Drug Sales Market Share by Region (2026-2031)
Table 21. Global Meningioma Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Meningioma Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Meningioma Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Meningioma Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Meningioma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Meningioma Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Meningioma Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Meningioma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Meningioma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Meningioma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Meningioma Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Meningioma Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Meningioma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Meningioma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Meningioma Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Meningioma Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Meningioma Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Meningioma Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Meningioma Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meningioma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Meningioma Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Meningioma Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Meningioma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Meningioma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Meningioma Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Meningioma Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Meningioma Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Meningioma Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Meningioma Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Meningioma Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Meningioma Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Meningioma Drug Sales Market Share by Type (2020-2025)
Table 53. Global Meningioma Drug Sales Market Share by Type (2026-2031)
Table 54. Global Meningioma Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Meningioma Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Meningioma Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Meningioma Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Meningioma Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Meningioma Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Meningioma Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Meningioma Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Meningioma Drug Sales Market Share by Application (2020-2025)
Table 63. Global Meningioma Drug Sales Market Share by Application (2026-2031)
Table 64. Global Meningioma Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Meningioma Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Meningioma Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Meningioma Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Meningioma Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Meningioma Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Arno Therapeutics Inc Company Information
Table 71. Arno Therapeutics Inc Description and Business Overview
Table 72. Arno Therapeutics Inc Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Arno Therapeutics Inc Meningioma Drug Product
Table 74. Arno Therapeutics Inc Recent Developments/Updates
Table 75. AstraZeneca Plc Company Information
Table 76. AstraZeneca Plc Description and Business Overview
Table 77. AstraZeneca Plc Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. AstraZeneca Plc Meningioma Drug Product
Table 79. AstraZeneca Plc Recent Developments/Updates
Table 80. Boehringer Ingelheim GmbH Company Information
Table 81. Boehringer Ingelheim GmbH Description and Business Overview
Table 82. Boehringer Ingelheim GmbH Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Boehringer Ingelheim GmbH Meningioma Drug Product
Table 84. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 85. Eli Lilly and Co Company Information
Table 86. Eli Lilly and Co Description and Business Overview
Table 87. Eli Lilly and Co Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Eli Lilly and Co Meningioma Drug Product
Table 89. Eli Lilly and Co Recent Developments/Updates
Table 90. Genentech Inc Company Information
Table 91. Genentech Inc Description and Business Overview
Table 92. Genentech Inc Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Genentech Inc Meningioma Drug Product
Table 94. Genentech Inc Recent Developments/Updates
Table 95. GlaxoSmithKline Plc Company Information
Table 96. GlaxoSmithKline Plc Description and Business Overview
Table 97. GlaxoSmithKline Plc Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Plc Meningioma Drug Product
Table 99. GlaxoSmithKline Plc Recent Developments/Updates
Table 100. Merck & Co Inc Company Information
Table 101. Merck & Co Inc Description and Business Overview
Table 102. Merck & Co Inc Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Merck & Co Inc Meningioma Drug Product
Table 104. Merck & Co Inc Recent Developments/Updates
Table 105. Merck KGaA Company Information
Table 106. Merck KGaA Description and Business Overview
Table 107. Merck KGaA Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Merck KGaA Meningioma Drug Product
Table 109. Merck KGaA Recent Developments/Updates
Table 110. Novartis AG Company Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Novartis AG Meningioma Drug Product
Table 114. Novartis AG Recent Developments/Updates
Table 115. Ono Pharmaceutical Co Ltd Company Information
Table 116. Ono Pharmaceutical Co Ltd Description and Business Overview
Table 117. Ono Pharmaceutical Co Ltd Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Ono Pharmaceutical Co Ltd Meningioma Drug Product
Table 119. Ono Pharmaceutical Co Ltd Recent Developments/Updates
Table 120. Pharma Mar SA Company Information
Table 121. Pharma Mar SA Description and Business Overview
Table 122. Pharma Mar SA Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Pharma Mar SA Meningioma Drug Product
Table 124. Pharma Mar SA Recent Developments/Updates
Table 125. Progenics Pharmaceuticals Inc Company Information
Table 126. Progenics Pharmaceuticals Inc Description and Business Overview
Table 127. Progenics Pharmaceuticals Inc Meningioma Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Progenics Pharmaceuticals Inc Meningioma Drug Product
Table 129. Progenics Pharmaceuticals Inc Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Meningioma Drug Distributors List
Table 133. Meningioma Drug Customers List
Table 134. Meningioma Drug Market Trends
Table 135. Meningioma Drug Market Drivers
Table 136. Meningioma Drug Market Challenges
Table 137. Meningioma Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meningioma Drug
Figure 2. Global Meningioma Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meningioma Drug Market Share by Type: 2024 & 2031
Figure 4. Abemaciclib Product Picture
Figure 5. Afatinib Dimaleate Product Picture
Figure 6. AR-42 Product Picture
Figure 7. Avelumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global Meningioma Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Meningioma Drug Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Meningioma Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Meningioma Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Meningioma Drug Sales (2020-2031) & (K Pcs)
Figure 17. Global Meningioma Drug Average Price (USD/Pcs) & (2020-2031)
Figure 18. Meningioma Drug Report Years Considered
Figure 19. Meningioma Drug Sales Share by Manufacturers in 2024
Figure 20. Global Meningioma Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Meningioma Drug Players: Market Share by Revenue in Meningioma Drug in 2024
Figure 22. Meningioma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Meningioma Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Meningioma Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Meningioma Drug Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Meningioma Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Meningioma Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Meningioma Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Meningioma Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Taiwan Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Philippines Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Meningioma Drug Sales Market Share by Country (2020-2031)
Figure 48. Latin America Meningioma Drug Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Middle East and Africa Meningioma Drug Sales Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Meningioma Drug Revenue Market Share by Country (2020-2031)
Figure 54. Turkey Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. UAE Meningioma Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Global Sales Market Share of Meningioma Drug by Type (2020-2031)
Figure 58. Global Revenue Market Share of Meningioma Drug by Type (2020-2031)
Figure 59. Global Meningioma Drug Price (USD/Pcs) by Type (2020-2031)
Figure 60. Global Sales Market Share of Meningioma Drug by Application (2020-2031)
Figure 61. Global Revenue Market Share of Meningioma Drug by Application (2020-2031)
Figure 62. Global Meningioma Drug Price (USD/Pcs) by Application (2020-2031)
Figure 63. Meningioma Drug Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
